Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 26, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

The pathophysiology of thermoablation: optimizing cryoablation.

John G Baust1, Andrew A Gage, Anthony T Robilottto

  • 1Institute of Biomedical Technology, State University of New York, Binghamton, NY 13902-6000, USA. jgbaust@binghamton.edu

Current Opinion in Urology
|February 4, 2009
PubMed
Summary

Modern cryoablative techniques effectively treat prostate cancer, offering primary and salvage therapy options. Research is advancing freeze-sensitizing agents to enhance cryoablation efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Memoriam: Dr. Andrew A. Gage, M.D. (1922-2024).

Cryobiology·2025
Same author

Investigation of Lung Cancer Cell Response to Cryoablation and Adjunctive Gemcitabine-Based Cryo-Chemotherapy Using the A549 Cell Line.

Biomedicines·2024
Same author

The Assessment of a Novel Endoscopic Ultrasound-Compatible Cryocatheter to Ablate Pancreatic Cancer.

Biomedicines·2024
Same author

Evaluation of a New Cystoscopic Cryocatheter and Method for the <i>In Situ</i> Destruction of Bladder Cancer: Preliminary <i>In Vivo</i> Study.

Journal of endourology·2024
Same author

An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line.

Biomedicines·2022
Same author

Investigation of Bladder Cancer Cell Response to Cryoablation and Adjunctive Cisplatin Based Cryo/Chemotherapy.

Clinical research (Milpitas, Calif.)·2022

Area of Science:

  • Oncology
  • Urology
  • Thermal Medicine

Background:

  • Prostate cancer management options are evolving.
  • Thermal therapies, particularly cryoablation, are gaining attention for treating prostate and renal cancers.

Purpose of the Study:

  • To review the efficacy of thermal therapies for prostate cancer.
  • To emphasize the role and advancements in cryoablative techniques.

Main Methods:

  • Review of long-term follow-up studies on cryoablation.
  • Analysis of recent findings on cryoablation effectiveness at -40 degrees C.
  • Inclusion of adjunctive agents for enhanced cryoablation.

Main Results:

  • Modern cryoablation is effective for prostate cancer management.

More Related Videos

Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
06:25

Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation

Published on: March 15, 2020

Related Experiment Videos

Last Updated: Jun 26, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
06:25

Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation

Published on: March 15, 2020

  • American Urology Association guidelines recognize cryoablation for primary and salvage treatment.
  • -40 degrees C exposure is lethal to prostate cancer cells after double freeze-thaw cycles.

    • Conclusions:

    • Cryoablation is a significant thermal therapy for prostate cancer.
    • Understanding of cryoablation application and cell death mechanisms is established.
    • Development of freeze-sensitizing agents is key to improving cryoablation efficacy.